Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy.

ABSTRACT:

Background

Health system expenditure on cancer drugs is rising rapidly in many OECD countries given the costly new treatments and increased rates of use due to a growing and ageing population. These factors put considerable strain on the sustainability of health systems worldwide, sparking public debate among clinicians, pharmaceutical companies, policy-makers and citizens on issues of affordability and equity. We engaged Canadians through a series of deliberative public engagement events to determine their priorities for making cancer drug funding decisions fair and sustainable in Canada's publicly financed health system.

Methods

An approach to deliberation was developed based on the McMaster Health Forum's citizen panels and the established Burgess and O'Doherty model of d

SUBMITTER: Bentley C 

PROVIDER: S-EPMC6367823 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature